NRAS and vaginal melanoma: Specifically, in a study involving 30 patients with vulvar and vaginal melanomas, BRAF and NRAS mutations exhibited a 7% and 10% frequency, respectively [24], while similar low frequencies of BRAF mutation ranging from 0% to 12.5% have been detected in other studies [26, 27, 37].